317 results match your criteria: "Centre Hospitalier Annecy-Genevois[Affiliation]"
Arch Cardiovasc Dis
December 2022
Université de Paris, PARCC, INSERM, 75015 Paris, France; Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France.
Background: The evolution of patients hospitalized with coronavirus disease 2019 (COVID-19) is still hard to predict, even after several months of dealing with the pandemic.
Aims: To develop and validate a score to predict outcomes in patients hospitalized with COVID-19.
Methods: All consecutive adults hospitalized for COVID-19 from February to April 2020 were included in a nationwide observational study.
J Clin Med
November 2022
Department of Pharmacy, University Hospital of Besançon, 25056 Besançon, France.
Background: Given the rapidly evolving pandemic of COVID-19 in 2020, authorities focused on the repurposing of available drugs to develop timely and cost-effective therapeutic strategies. Evidence suggested the potential utility of remdesivir in the framework of an early access program. REMDECO-19 is a multicenter national cohort study assessing the ability of remdesivir to improve the outcome of patients hospitalized with COVID-19.
View Article and Find Full Text PDFCancers (Basel)
November 2022
Medical Oncology Department, Centre Léon Bérard/Research Center of Lyon (CRCL), UMR INSERM 1052, 28 rue Laennec, 69008 Lyon, France.
Background and aims: Pancreatic cancer is highly lethal and often diagnosed at an advanced stage. This cohort study analyzes the impact of care pathways, delays, and socio-spatial determinants on pancreatic cancer patients’ diagnosis, treatment, and prognosis. Method: Patients with pancreatic adenocarcinoma newly diagnosed at all stages between January and June 2016 in the AuRA French region were included.
View Article and Find Full Text PDFJ Perinatol
February 2023
Division of Neonatology, Department of Pediatrics, CHU Sainte-Justine, Université de Montreal, Montréal, QC, Canada.
Objective: To assess the educational and clinical impact of a tiny baby intubation team (TBIT).
Study Design: Retrospective study comparing endotracheal intubation (ETI) performed: pre-implementation of a TBIT (T1), 6 months post-implementation (T2), and 4 years post-implementation (T3).
Results: Post-implementation (T2), first-attempt success rate in tiny babies increased (44% T1; 59% T2, p = 0.
J Infect
December 2022
Centre de référence pour la prise en charge des infections ostéo-articulaires complexes (CRIOAc Lyon, www.crioac-lyon.fr), Hospices Civils de Lyon, Lyon, France; CIRI - Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Univ Lyon, F-69007, Lyon, France; Service des maladies infectieuses et tropicales, Hospices Civils de Lyon, Lyon, France. Electronic address:
Objectives: To describe Staphylococcus lugdunensis prosthetic joint infection (PJI) management and outcome.
Methods: Adults with proven S. lugdunensis PJI were included in a multicentric retrospective cohort.
Hum Vaccin Immunother
November 2022
Service d'Infectiologie, Hôpital Nord-CHU Saint Etienne, Saint-Etienne, France.
The lifting of non-pharmaceutical measures preventing transmission of SARS-CoV-2 (and other viruses, including influenza viruses) raises concerns about healthcare resources and fears of an increased number of cases of influenza and COVID-19. For the 2021-2022 influenza season, the WHO and >20 European countries promoted coadministration of influenza and COVID-19 vaccines. Recently, the French Health Authority recommended coupling the COVID-19 vaccination with the 2022-2023 influenza vaccination campaign for healthcare professionals and people at risk of severe COVID-19.
View Article and Find Full Text PDFClin Microbiol Infect
February 2023
Université Paris Cité, INSERM, IAME UMR 1137, Paris, France; INSERM, Centre d'Investigation clinique 1425, Hôpital Bichat, Paris, France; AP-HP.Nord, Département d'Epidémiologie Biostatistique et Recherche Clinique, Hôpital Bichat, Paris, France. Electronic address:
In the era of personalized treatment in multiple myeloma, high-risk patients must be accurately identified. The International Myeloma Working Group recommends using the Revised International Staging System (R-ISS) to pick out high-risk patients. The main purpose of our work was to explore the heterogeneity of outcome among R-ISS stage II patients assessing the impact of International Staging System (ISS) stage, chromosomal abnormalities and lactate dehydrogenase level in this subgroup.
View Article and Find Full Text PDFLancet Reg Health Eur
November 2022
Department of Thoracic Oncology, CHU de Lille, CNRS, Inserm, Institut Pasteur de Lille, UMR9020-U1277-CANTHER, Lille, France.
Background: Long-term changes in lung cancer (LC) patients are difficult to evaluate. We report results from the French KBP-2020 real-life cohort.
Methods: KBP-2020 was a prospective cohort that included all patients diagnosed with LC in 2020, in nonacademic public hospital in France.
PLoS One
September 2022
Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1294, Saint Etienne, France.
In the last decade, a large number of clinical trials have been deployed using Cardiac Magnetic Resonance (CMR) to evaluate cardioprotective strategies aiming at reducing the irreversible myocardial damage at the time of reperfusion. In these studies, segmentation and quantification of myocardial infarct lesion are often performed with a commercial software or an in-house closed-source code development thus creating a barrier for reproducible research. This paper introduces CMRSegTools: an open-source application software designed for the segmentation and quantification of myocardial infarct lesion enabling full access to state-of-the-art segmentation methods and parameters, easy integration of new algorithms and standardised results sharing.
View Article and Find Full Text PDFLancet Healthy Longev
March 2022
GINECO, Paris, France; Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
Leukemia
October 2022
The European Myelodysplastic Neoplasms Cooperative Group (EMSCO), Leipzig, Germany.
Pharmaceutics
August 2022
Department of Hematology, Centre Hospitalier de Versailles, 78157 Le Chesnay, France.
Eur J Clin Microbiol Infect Dis
September 2022
Institut Micalis UMR 1319, Université Paris-Saclay, INRAeChâtenay Malabry, AgroParisTech, France.
Treatment of infective endocarditis (IE) is based on high doses of antibiotics with a prolonged duration. Therapeutic drug monitoring (TDM) allows antibiotic prescription optimization and leads to a personalized medicine, but no study evaluates its interest in the management of IE. We conducted a retrospective, bicentric, descriptive study, from January 2007 to December 2019.
View Article and Find Full Text PDFAnn Cardiol Angeiol (Paris)
October 2022
Centre Hospitalier Annecy-Genevois, 74000 Annecy, France.
Objective: To assess the quality of life (QOL) and describe associated factors in patients with chronic heart failure (HF) living in a low-income population in West Africa.
Methods: This is was a cross-sectional study conducted from January 2017 to June 2018, in the department of cardiology of the University Teaching Hospital (CHU-Campus) in Lomé (Togo). Enrolled patients had stable chronic HF and have been hospitalized in the past 6 months; QOL was assessed using the Minnesota Living with Heart Failure questionnaire (MLHFQ).
Lancet Infect Dis
October 2022
Centre Hospitalier Annecy Genevois, 74370 Epagny Metz-Tessy, France; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, F-75012, Paris, France. Electronic address:
AJR Am J Roentgenol
March 2023
Institute of Radiology, University of Verona, Verona, Italy.
Mol Diagn Ther
September 2022
Laboratoire de Cardiogénétique Moléculaire, Centre de Biologie et Pathologie Est, Hospices Civils de Lyon, 69677, Bron, Cedex, France.
Background And Objective: Pediatric cardiomyopathies are clinically heterogeneous heart muscle disorders associated with significant morbidity and mortality for which substantial evidence for a genetic contribution was previously reported. We present a detailed molecular investigation of a cohort of 231 patients presenting with primary cardiomyopathy below the age of 18 years.
Methods: Cases with pediatric cardiomyopathies were analyzed using a next-generation sequencing (NGS) workflow based on a virtual panel including 57 cardiomyopathy-related genes.
Ann Rheum Dis
October 2022
Dermatology, Hopital Saint-Louis, Paris, Île-de-France, France.
Objective: To quantify the risk of immune-related adverse events (irAEs) in patients with pre-existing autoimmune disease (pAID) treated by immune checkpoint inhibitors (ICIs) for stage III or IV melanoma.
Methods: Case-control study performed on a French multicentric prospective cohort of patients with melanoma, matched for irAE risk factors and oncological staging. Risk of irAE was assessed by logistic regression.
Eur J Cancer
September 2022
Centre de Recherche INSERM LNC-UMR1231, F-21000 Dijon, France; University of Burgundy Franche-Comté, F-21000 Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000 Dijon, France; Genetic and Immunology Medical Institute, Dijon, France; Department of Medical Oncology, Centre Georges-François Leclerc, F-21000 Dijon, France. Electronic address:
Aim: Stratification of colon cancer (CC) of patients with stage II and III for risk of relapse is still needed especially to drive adjuvant therapy administration. Our study evaluates the prognostic performance of two known biomarkers, CDX2 and CD3, standalone or their combined information in stage II and III CC.
Patients And Methods: CDX2 and CD3 expression was evaluated in Prodige-13 study gathering 443 stage II and 398 stage III primary CC on whole slide colectomy.
Clin Microbiol Infect
December 2022
Groupe Vaccination-Prévention de La Société de Pathologie Infectieuse de Langue Française (SPILF), France; Department of Internal Medicine and Infectious Diseases, University Hospital of Poitiers; Poitiers, France.
Haematologica
December 2022
Groupe Fi-LMC, Centre Léon Bérard, Lyon, France; Hematology department, Institut Bergonié, Bordeaux, France.
Bull Cancer
July 2022
ICANS, Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
Introduction: Today, patients with lung cancer and their relatives can easily search information on the Internet and express themselves online.
Methods: Within this web-ethnographic research, we found, based on 246 search terms related to lung cancer, and collected, a sample of 136 online conversations that were published between January 2004 and September 2018, including 1220 messages by 762 authors.
Results: The authors of messages, many of them close relatives of patients (35%), share their experience (34%).
EClinicalMedicine
June 2022
Centre d'Investigations Cliniques (CIC 1417) Cochin Pasteur, AP-HP, Hôpital Cochin, Paris, France.
J Appl Clin Med Phys
July 2022
Department of Physics, Centre Georges François Leclerc, Dijon, France.
Intensity modulation treatments are widely used in radiotherapy because of many known advantages. In this context, the picket fence test (PF) is a relevant test to check the Multileaf Collimator (MLC) performances. So this work compares and evaluates three analysis platforms for the PF used routinely by three different institutions.
View Article and Find Full Text PDF